← Leaderboards
Antoine Louveau
Cleveland Clinic Lerner Com-Cwru
$2,094,739
Attributed
$2,094,739
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,094,739 · 4
By mechanism
R56$1,410,489 · 2
R21$442,750 · 1
R01$241,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Silvio Danese$608,108
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposMolecularNeurodegenerative DisordersTranscriptomicsMouse ModelFunctional DisorderSocialSignal TransductionRegulationBehavioralPathway InteractionsBrainMeningesMeningealGenesMeningeal Lymphatic SystemMorphologyLymphatic Endothelial CellsBehaviorCerebrospinal FluidCellsLymphatic DysfunctionLymphatic FunctionHomeostasis
Grant awards (5)
Lymphatic dysfunction in neurodevelopmental disorders and associated behaviors$241,500
R01 · FY2025 · MH · contact PI
Lymphatic dysfunction in neurodevelopmental disorders and associated behaviors$402,500
R56 · FY2024 · MH · contact PI
Integrin regulation of vascular function in Alzheimer's disease$605,489
R56 · FY2023 · AG · contact PI
Lymphatic dysfunction in neurodevelopmental disorders and associated behaviors$402,500
R56 · FY2023 · MH · contact PI
Integrin mediated regulation of lymphatics during aging and neurodegeneration$442,750
R21 · FY2022 · AG · contact PI